CDH2 and hepatocellular carcinoma: Consistently, experimental assays confirmed that CSNK1D promoted EMT of HCC cells, as evidenced by increased N-cadherin, Vimentin, and Snail expression and decreased E-cadherin expression (Fig. 5G).